>_ QFI Terminal
Terminal › Stocks › NVS

Novartis AG (NVS) Stock

Healthcare · Drug Manufacturers - General · CH
$160.32 -1.80%
Last updated Nov 12, 2026 09:20 UTC

NVS Key Statistics

Market Cap$302.78B
P/E (TTM)30.60
P/S (TTM)5.38
P/B (TTM)8.06
Revenue (TTM)$56.31B
EPS (TTM)$5.24
Dividend Yield2.70%
ROE (TTM)24.24%
Net Margin18.06%
Gross Margin74.30%
52W High$170.46
52W Low$123.24
Analyst ViewHold
Price Target$149.50
Employees75,267
Volume2,321,948

About Novartis AG

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

CEO: Vasant Narasimhan. Company website

NVS — Frequently Asked Questions

What is the NVS stock price today?

Novartis AG (NVS) trades at $160.32, down 1.80% on the day, as of Nov 12, 2026 09:20 UTC.

What is Novartis AG's market cap?

Novartis AG has a market capitalisation of $302.78B, calculated from the live NVS share price and shares outstanding.

What is the P/E ratio of NVS?

NVS trades at a trailing P/E of 30.60, from earnings per share of $5.24 over the last twelve months.

How much revenue does Novartis AG make?

Novartis AG generated revenue of $56.31B over the trailing twelve months, which puts the stock at 5.38 times sales.

Does NVS pay a dividend?

Yes. Novartis AG pays a dividend yielding 2.70% on the current share price.

What is the 52-week range for NVS?

NVS has traded between $123.24 and $170.46 over the past 52 weeks, and the last price is 5.9% below that high.

Is Novartis AG profitable?

Yes. Novartis AG keeps 18.06% of revenue as net income over the trailing twelve months.

What is the analyst price target for NVS?

Wall Street analysts rate NVS Hold, with an average price target of $149.50, 6.7% below the current price.

What sector is Novartis AG in?

Novartis AG is classified under the Healthcare sector and the Drug Manufacturers - General industry, and is domiciled in CH.

Who is the CEO of Novartis AG?

Vasant Narasimhan is the chief executive of Novartis AG, which employs 75,267 people.

Where can I track NVS in real time?

QFI Terminal shows NVS with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See NVS live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open NVS in Terminal See plans

Drug Manufacturers - General stocks

NVO Novo Nordisk A/S JNJ Johnson & Johnson LLY Eli Lilly and Company MRK Merck & Co., Inc. ABBV AbbVie Inc. PFE Pfizer Inc. AZN AstraZeneca PLC SNY Sanofi BMY Bristol-Myers Squibb Company AMGN Amgen Inc. GSK GSK plc GILD Gilead Sciences, Inc. BIIB Biogen Inc. OGN Organon & Co. SCLX Scilex Holding Company

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. CI Cigna Corporation CAH Cardinal Health, Inc. CNC Centene Corp. ELV Elevance Health Inc. HUM Humana Inc. HCA HCA Healthcare, Inc. ABT Abbott Laboratories TMO Thermo Fisher Scientific Inc. MOH Molina Healthcare, Inc. MDT Medtronic Plc MDLN Medline Inc. SYK Stryker Corporation DHR Danaher Corporation THC Tenet Healthcare Corporation GEHC GE HealthCare Technologies Inc. BSX Boston Scientific Corporation BDX Becton, Dickinson and Company FMS Fresenius Medical Care AG & Co. KGaA UHS Universal Health Services, Inc. OSCR Oscar Health, Inc. IQV IQVIA Holdings Inc.

ETFs holding NVS

BNDX Vanguard Total International Bond ETF 0.00%

Largest institutional holders of NVS

Fisher Asset Management, LLC 16,762,528 shares
MORGAN STANLEY MS 8,726,827 shares
DIMENSIONAL FUND ADVISORS LP 7,875,541 shares
PRIMECAP MANAGEMENT CO/CA/ 6,592,124 shares
LOOMIS SAYLES & CO L P 5,239,309 shares
FRANKLIN TEMPLETON INC 3,251,281 shares
FRANKLIN RESOURCES INC BEN 3,251,281 shares
BlackRock, Inc. BLK 3,047,988 shares
GOLDMAN SACHS GROUP INC GS 2,980,168 shares